Navigation Links
Savient Pharmaceuticals Reports First Quarter 2009 Financial Results
Date:5/6/2009

NFERENCE CALL

Savient will host a live web cast to review first quarter 2009 results on May 7, 2009 at 10:00 a.m. EDT. Both the live and archived web cast can be accessed from the Investor Relations page of Savient's website at http://www.savient.com. A digital recording of the web cast will be available approximately one-hour following the conclusion of the call and will be available for fourteen days. A telephone replay will be available from 1:00 p.m. EDT on May 7, 2009 through 11:59 p.m. EDT on May 21, 2009. To access the recording, use the Dial-In Number and the Conference ID listed below:

Dial: (888) 203-1112 (domestic) or (719) 457-0820 (international)

Conf ID: 4393613

ABOUT SAVIENT PHARMACEUTICALS, INC.

Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and marketing pharmaceutical products that target unmet medical needs in both niche and broader specialty markets. Savient's product development candidate, KRYSTEXXA(TM) (pegloticase) for treatment failure gout has reported positive Phase 1, 2 and 3 clinical data. The KRYSTEXXA Phase 3 clinical studies were completed in October 2007; the BLA was filed with the FDA in October 2008 and the FDA granted priority review status in December 2008. The Company submitted amendments to the BLA to the FDA in January 2009 and the FDA extended the review period by three months, revising the PDUFA date to August 1, 2009. Savient has exclusively licensed worldwide rights to the technology related to KRYSTEXXA, formerly referred to as Puricase(R), from Duke University and Mountain View Pharmaceuticals, Inc. Savient also manufactures and supplies Oxandrin(R) (oxandrolone tablets, USP) CIII in the U.S. Further information on Savient can be accessed by visiting: '/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Savient Pharmaceuticals to Hold Third Quarter 2008 Financial Results Conference Call on Thursday, November 6, 2008
2. Savients Pegloticase Data in Treatment-Failure Gout Patients Presented at 72nd Annual Meeting of the American College of Rheumatology Conference
3. Savient Submits Biologics License Application (BLA) for pegloticase
4. Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results
5. Savient Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference on November 18th
6. Savient Announces Appointment of David Gionco as Chief Financial Officer
7. Savient Pharmaceuticals to Hold Fourth Quarter and Year-End 2008 Results Conference Call on Thursday, February 26, 2009
8. Savient Pharmaceuticals to Raise $31 Million Through Registered Direct Offering
9. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
10. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... Vegalab announced the acquisition of Ecowin, a ... As part of the acquisition, Ecowin rebranded itself as ... role as CEO for the company,s Korea operations. ... alongside Koo and oversee developments at the new location. ... Koo founded Ecowin in 2008 to great ...
(Date:3/4/2015)... , March 4, 2015 ... Paris en décembre 2011, ... SARAH   », qui compare   l ... le   sorafénib dans le carcinome hépatocellulaire avancé, ... cancer du foie avancé   ; les résultats ...
(Date:3/3/2015)... SAN DIEGO , March 3, 2015  Halozyme Therapeutics, ... the Barclays 2015 Global Healthcare Conference in Miami, ... ET/10:05 a.m. PT. David A. Ramsay , Chief Financial ... will be webcast through the "Investors" section of Halozyme,s corporate ... made available for 90 days following the event. To access ...
(Date:3/3/2015)... , March 3, 2015 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" ...  The orders are for odour control projects in North ... Asia . "Bidding activity in 2015 ... and CEO. "After a high volume year for bidding in 2014, ... New Year.  The recent orders reflect the organization,s renewed focus on ...
Breaking Biology Technology:Korean Government Program Supports Vegalab's Research and Development 2Korean Government Program Supports Vegalab's Research and Development 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 2Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 4Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 5Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 6Halozyme Therapeutics To Present At The Barclays 2015 Global Healthcare Conference 2
... , LACHEN, SWITZERLAND and HOBOKEN, N.J., Sept. ... submitted its Biological License Application for octagam(R) 10% ... Food and Drug Administration (FDA) with the goal of ... 2010. The application was submitted for the treatment of Idiopathic Thrombocytopenic ...
... ... launched its revolutionary Trusted LASIK Surgeons directory service and website at ... vision and find a highly qualified LASIK surgeon who can help improve ... directory apart is a unique screening process ensuring that only those who ...
... fluid boils in tiny "microchannels" has led to formulas ... cool high-power electronics in electric and hybrid cars, aircraft, ... boil in cooling systems dramatically increases how much heat ... to below its boiling point, said Suresh Garimella, the ...
Cached Biology Technology:Octapharma Aims to Expand U.S. Immune Globulin Therapy Portfolio 2Octapharma Aims to Expand U.S. Immune Globulin Therapy Portfolio 3LASIK Surgery Specialist G. Brock Magruder, Jr., M.D. of LaserVue Lasik Center of Orlando Joins the Trusted LASIK Surgeons Directory 2LASIK Surgery Specialist G. Brock Magruder, Jr., M.D. of LaserVue Lasik Center of Orlando Joins the Trusted LASIK Surgeons Directory 3LASIK Surgery Specialist G. Brock Magruder, Jr., M.D. of LaserVue Lasik Center of Orlando Joins the Trusted LASIK Surgeons Directory 4LASIK Surgery Specialist G. Brock Magruder, Jr., M.D. of LaserVue Lasik Center of Orlando Joins the Trusted LASIK Surgeons Directory 5LASIK Surgery Specialist G. Brock Magruder, Jr., M.D. of LaserVue Lasik Center of Orlando Joins the Trusted LASIK Surgeons Directory 6LASIK Surgery Specialist G. Brock Magruder, Jr., M.D. of LaserVue Lasik Center of Orlando Joins the Trusted LASIK Surgeons Directory 7New findings could help hybrid, electric cars keep their cool 2New findings could help hybrid, electric cars keep their cool 3New findings could help hybrid, electric cars keep their cool 4
(Date:2/5/2015)... FRANCISCO , January 28, 2015 ... Market Analysis, Size And Segment Forecasts To 2020 has ... global IR camera market is expected to reach USD ... by Grand View Research, Inc. IR cameras help identify ... and are expected to witness surging demand in medical ...
(Date:2/5/2015)... Calif. , Feb. 3, 2015 ... technology, demand from industries such as consumer electronics, ... market for surface mount technology (SMT) screen printers. ... to automatic control will push the adoption curve ... will remain steady as glue dispensers are indispensable ...
(Date:1/22/2015)... 13, 2015  Today, FreeWavz ( www.FreeWavz.com ), the ... campaign on Fundable, https://www.fundable.com/freewavz . FreeWavz will ... capacity to meet customer demand. Logo ... http://photos.prnewswire.com/prnh/20150113/168790 Invented by Dr. ...
Breaking Biology News(10 mins):IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 2End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 3FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2
... The brain is a "time machine," assert Duke neuroscientists ... brain tracks time is essential to understanding all its ... of activities from communicating, to orchestrating movement, to getting ... the October 2005 Nature Reviews Neuroscience, Buhusi and Meck ...
... in two immune system disorders that leave affected ... according to new findings reported in the August ... to new diagnostic tests for these two inherited ... immunodeficiency (CVID). Currently, doctors diagnose the conditions by ...
... turn genes on and off now looks to be more ... at the University of Utah, report in the July 1, ... for the first time that when certain parts of a ... be only minor players in the protein world ?they become ...
Cached Biology News:What Makes The Brain Tick, Tick, Tick: Researchers Gaining New Insights Into Brain's Internal Clock 2What Makes The Brain Tick, Tick, Tick: Researchers Gaining New Insights Into Brain's Internal Clock 3What Makes The Brain Tick, Tick, Tick: Researchers Gaining New Insights Into Brain's Internal Clock 4Defective Gene Linked to Two Inherited Immune Deficiencies 2Defective Gene Linked to Two Inherited Immune Deficiencies 3A 'dimmer switch' for genes 2A 'dimmer switch' for genes 3